Results 321 to 330 of about 691,603 (403)

Methylation‐based alcohol consumption scores as prognostic biomarkers in colorectal cancer: Insights from a population‐based cohort

International Journal of Cancer, EarlyView.
What's New? Alcohol's prognostic role in colorectal cancer remains uncertain, partly due to biases in self‐reported intake. This is the first study to evaluate blood DNA methylation‐based alcohol consumption scores as prognostic biomarkers in colorectal cancer.
Tanwei Yuan, Katrin E. Tagscherer, Wilfried Roth, Melanie Bewerunge‐Hudler, Alexander Brobeil, Matthias Kloor, Hendrik Bläker, Hermann Brenner, Michael Hoffmeister   +8 more
wiley   +1 more source

Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma. [PDF]

Liver Int
Xiang X, Shetty K, Yu H, Mishra B, Wong LL, Zhou XJ, Satapathy SK, Crawford JM, Latham PS, Han SH, Mathew B, Dagher NN, Lau L, Cacaj F, Vegesna AK, Dasarathy S, He AR, Huang H, Amdur RL, Mishra L.   +19 more
europepmc   +1 more source

Genetic variants underlying precancerous conditions of hepatocellular carcinoma

International Journal of Cancer, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for 80% of cases worldwide. While chronic hepatitis B and C infections remain primary risk factors, emerging evidence highlights the increasing contributions of metabolic dysfunction‐associated steatotic liver disease (MASLD) and alcohol‐associated liver disease
Jonathan Jaime G. Guerrero, Paolo C. Encarnacion, Mark Angelo S. del Rosario, Matthew Aldren S. Ora, Jiayan Zhou, Kin Israel Notarte, Wan‐Chun Li, Ching‐Wen Chang   +7 more
wiley   +1 more source

Editorial: Treatment and prognostic assessment of liver cirrhosis and its complications, volume II

Frontiers in Medicine
Wei Zhang, Yufu Tang, Hao Wu, Andrea Mancuso, Thierry Thévenot, Xingshun Qi   +5 more
doaj   +1 more source

Therapeutic outcomes and predictors of efficacy for endoscopic variceal ligation plus propranolol in liver cirrhosis-related upper gastrointestinal bleeding. [PDF]

World J Gastrointest Surg
Gong DF, Cheng L.
europepmc   +1 more source

Increased incidence, survival, and registration quality of primary hepato‐pancreato‐biliary cancers in the Netherlands Cancer Registry

International Journal of Cancer, EarlyView.
What's New? Primary hepato‐pancreato‐biliary cancers have poor prognosis and their reporting often scores low on standard data quality indicators in population‐based cancer registries. This comprehensive evaluation of cases in the Netherlands Cancer Registry shows that both the incidence and survival rates of most primary hepato‐pancreato‐biliary ...
Lydia G. van der Geest, Marianne van der Mark, Joanne Verheij, Arantza Farina Sarasqueta, Judith de Vos‐Geelen, Marc G. Besselink, Vincent E. de Meijer, Ignace H. J. T. de Hingh, Bert A. Bonsing, Philip R. de Reuver, Francois E. J. A. Willemssen, Pauline A. J. Vissers, Otto Visser, the Dutch Pancreatic Cancer Group and the Dutch Hepatocellular & Cholangiocarcinoma Group   +13 more
wiley   +1 more source

Construction and validation of a machine learning-based model predicting early readmission in patients with decompensated cirrhosis: a prospective two-center cohort study. [PDF]

BioData Min
Yang F, Li J, Yang Z, Wu L, Wang H, Sun C.   +5 more
europepmc   +1 more source

Mortality from cancer and non‐cancer diseases in the Lithuanian cohort of Chernobyl cleanup workers (2001–2020)

International Journal of Cancer, EarlyView.
What's New? Following the Chernobyl disaster, workers were recruited from formerly Soviet‐occupied areas, including Lithuania, to participate in clean‐up efforts. Radiation exposure incurred by workers during these efforts offers a unique opportunity for the study of long‐term health effects.
Rita Steponaviciene, Ausrele Kesminiene, Auguste Kaceniene, Giedre Smailyte   +3 more
wiley   +1 more source

The IC3 trial: protocol for a multicentre individually randomised controlled trial to compare a cirrhosis detection and hepatocellular carcinoma surveillance pathway vs usual care in Australian general practice for 45-75 years old with risk factors for chronic liver disease. [PDF]

Trials
Adams LA, de Guingand D, Jeffrey GP, Thompson AJ, Strasser SI, Crawford D, Collins L, Reid C, Wallace M, Chondros P, Allard N, Kirke A, Rutherford C, Hespe C, Partanen R, Frear S, Napreet H, Piakis K, Maas C, White OJ, Laughlin A, Clinton-McHarg T, Clymer C, Boyd L, Emery J.   +24 more
europepmc   +1 more source